| Jagpal S Sahota, MD | |
|
4201 W Medical Center Dr, Mchenry, IL 60050-8409 | |
| (815) 759-4323 | |
| (815) 759-4948 |
| Full Name | Jagpal S Sahota |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 25 Years |
| Location | 4201 W Medical Center Dr, Mchenry, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083712202 | NPI | - | NPPES |
| 1083712202 | Medicaid | MO | |
| P00650205 | Other | MO | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2006023095 (Missouri) | Secondary |
| 208M00000X | Hospitalist | 036115994 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Javon Bea Hospital | Rockford, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rockford Health Physicians | 2567374036 | 289 |
News Archive
The U.S. Food and Drug Administration today approved the 4 milligram maximum dose of Livalo (pitavastatin), a drug intended to improve blood cholesterol levels in persons with elevated or abnormal blood cholesterol levels.
MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study.
Improving health and economic costs after road traffic injuries is the focus of a new University of Queensland-led Centre of Research Excellence awarded $2.5 million by the National Health and Medical Research Council.
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced a series of investments and new technologies designed to extend the use of sequencing in the research arena and make it more relevant for physicians.
› Verified 6 days ago
| Entity Name | Rockford Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043242886 PECOS PAC ID: 2567374036 Enrollment ID: O20031103000584 |
News Archive
The U.S. Food and Drug Administration today approved the 4 milligram maximum dose of Livalo (pitavastatin), a drug intended to improve blood cholesterol levels in persons with elevated or abnormal blood cholesterol levels.
MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study.
Improving health and economic costs after road traffic injuries is the focus of a new University of Queensland-led Centre of Research Excellence awarded $2.5 million by the National Health and Medical Research Council.
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced a series of investments and new technologies designed to extend the use of sequencing in the research arena and make it more relevant for physicians.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jagpal S Sahota, MD 4201 W Medical Center Dr, Mchenry, IL 60050-8409 Ph: (815) 759-4323 | Jagpal S Sahota, MD 4201 W Medical Center Dr, Mchenry, IL 60050-8409 Ph: (815) 759-4323 |
News Archive
The U.S. Food and Drug Administration today approved the 4 milligram maximum dose of Livalo (pitavastatin), a drug intended to improve blood cholesterol levels in persons with elevated or abnormal blood cholesterol levels.
MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study.
Improving health and economic costs after road traffic injuries is the focus of a new University of Queensland-led Centre of Research Excellence awarded $2.5 million by the National Health and Medical Research Council.
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced a series of investments and new technologies designed to extend the use of sequencing in the research arena and make it more relevant for physicians.
› Verified 6 days ago
Dr. Cory Edward Mellon, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-759-4323 Fax: 815-759-4948 | |
Bilal Khan, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-759-4323 Fax: 815-759-4948 | |
Dr. Iqbal Bhwani, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-344-5000 | |
Sarah Quraishi, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-759-4323 Fax: 815-759-4948 | |
Mohammed Mubbasheer Shaik, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-759-4323 Fax: 815-759-4948 | |
Parag Kiran Amin, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4309 W Medical Center Dr Ste A102, Mchenry, IL 60050 Phone: 815-759-4323 | |
Muhammad Javaid Akbar, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-759-4323 Fax: 815-759-4948 |